Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | NTSR2 | O95665 | 10/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 10/20 | 0.46 |
| ▸ | SORT1 | Q99523 | 6/20 | 0.46 |
| ▸ | REN | P00797 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3857343 | 1.00 | CAPN1 (0.51) | CAPN1KMT2ASLC6A2CTSBNTSR2 | |
| SCHEMBL29351166 | 0.98 | KMT2A (0.51) | CAPN1KMT2ASLC6A2CTSBNTSR2 | |
| SCHEMBL3857550 | 0.95 | CAPN1 (0.55) | CAPN1KMT2ASLC6A2CTSBNTSR2 | |
| SCHEMBL3857546 | 0.95 | CAPN1 (0.55) | CAPN1KMT2ASLC6A2CTSBNTSR2 | |
| SCHEMBL29352557 | 0.94 | CAPN1 (0.50) | CAPN1KMT2ASLC6A2NTSR2NTSR1 | |
| SCHEMBL32681284 | 0.93 | CAPN1 (0.53) | CAPN1KMT2ASLC6A2CTSBNTSR2 | |
| SCHEMBL29722113 | 0.92 | CAPN1 (0.54) | CAPN1KMT2ASLC6A2CTSBNTSR2 | |
| SCHEMBL30072960 | 0.91 | CAPN1 (0.48) | CAPN1CTSBNTSR2NTSR1SORT1 | |
| SCHEMBL31070378 | 0.90 | CAPN1 (0.56) | CAPN1KMT2ACTSBNTSR2NTSR1 | |
| SCHEMBL31070369 | 0.90 | CAPN1 (0.56) | CAPN1KMT2ACTSBNTSR2NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040259795-A1 | Induction of antibiotic proteins and peptides by LAIT/sCD14-protein | GEMMA BIOTECHNOLOGY LTD. (CA) | 2004-12-23 | — | — | US | claimed |
| CN-1322214-A | Induction of avidin and of Antibioticpeptide Using LAIT/sCD 14-protein | GEMMA BIOTECHNOLOGY LTD (CA) | 2001-11-14 | — | — | CN | claimed |
| EP-1080111-B1 | THE INDUCTION OF ANTIOBIOTIC PEPTIDES BY LAIT (SCD14) PROTEIN | GEMMA BIOTECHNOLOGY LTD (CA) | 2012-07-25 | — | — | EP | disclosed |
| EP-1080111-B1 | THE INDUCTION OF ANTIOBIOTIC PEPTIDES BY LAIT (SCD14) PROTEIN | GEMMA BIOTECHNOLOGY LTD (CA) | 2012-07-25 | — | — | EP | disclosed |
| US-7592310-B2 | Induction of antibiotic proteins and peptides by LAIT/sCD14-protein | GEMMA BIOTECHNOLOGY LTD. (CA) | 2009-09-22 | — | — | US | disclosed |
| US-7592310-B2 | Induction of antibiotic proteins and peptides by LAIT/sCD14-protein | GEMMA BIOTECHNOLOGY LTD. (CA) | 2009-09-22 | — | — | US | disclosed |
| US-20040259795-A1 | Induction of antibiotic proteins and peptides by LAIT/sCD14-protein | GEMMA BIOTECHNOLOGY LTD. (CA) | 2004-12-23 | — | — | US | disclosed |
| US-20040259795-A1 | Induction of antibiotic proteins and peptides by LAIT/sCD14-protein | GEMMA BIOTECHNOLOGY LTD. (CA) | 2004-12-23 | — | — | US | disclosed |
| CN-1322214-A | Induction of avidin and of Antibioticpeptide Using LAIT/sCD 14-protein | GEMMA BIOTECHNOLOGY LTD (CA) | 2001-11-14 | — | — | CN | disclosed |
| EP-1080111-A2 | THE INDUCTION OF ANTIOBIOTIC PEPTIDES BY LAIT (SCD14) PROTEIN | Gemma Biotechnology Ltd. (CA) | 2001-03-07 | — | — | EP | disclosed |
| EP-1080111-A2 | THE INDUCTION OF ANTIOBIOTIC PEPTIDES BY LAIT (SCD14) PROTEIN | Gemma Biotechnology Ltd. (CA) | 2001-03-07 | — | — | EP | disclosed |
| WO-1999061468-A3 | THE INDUCTION OF ANTIBIOTIC PEPTIDES BY LAIT (SCD14) PROTEIN | GEMMA BIOTECHNOLOGY LTD (CA) | 2000-04-06 | — | — | WO | disclosed |
| WO-1999061468-A2 | THE INDUCTION OF ANTIBIOTIC PEPTIDES BY LAIT (SCD14) PROTEIN | GEMMA BIOTECHNOLOGY LTD. (CA) | 1999-12-02 | — | — | WO | disclosed |
| WO-1999061468-A2 | THE INDUCTION OF ANTIBIOTIC PEPTIDES BY LAIT (SCD14) PROTEIN | GEMMA BIOTECHNOLOGY LTD. (CA) | 1999-12-02 | — | — | WO | disclosed |